Business Context and Reporting Period
This Form 6-K filing by Therapix Biosciences Ltd. (not Scisparc Ltd.) covers the month of July 2020, with a report date of July 16, 2020. The document reports a corporate governance event rather than financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a disclosure regarding a board member resignation.
Material Changes
On July 15, 2020, Mr. Todd Violette resigned from the Board of Directors. The Company stated that this decision did not result from any disagreement with the Company.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the resignation event.
Investor Verification Checklist
- Verify the identity of the registrant as Therapix Biosciences Ltd., noting the discrepancy with the requested company name "Scisparc Ltd."
- Confirm the effective date of Mr. Todd Violette's resignation (July 15, 2020).
- Check subsequent filings for any appointment of a replacement director.
- Review the Company's Form 20-F for the most recent financial data, as this 6-K contains none.